Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases

References

• Abel L, Dcsscin A J. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997; 9: 509–16
   PubMed Web of Science ®Google Scholar
• Zinkernagel R M, Doherty P C. The discovery of MHC restriction. Immunol Today 1997; 18: 14–6
   PubMedGoogle Scholar
• Thursz M R, Thomas H C, Greenwood B M, Hill A VS. Hetero-zygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997; 17: 11–2
   PubMed Web of Science ®Google Scholar
• Dinarello C A. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095–147
   PubMed Web of Science ®Google Scholar
• Lennard A C. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15: 77–105
   PubMed Web of Science ®Google Scholar
• Mossman T R. Properties and functions on interleukin-10. Adv Immunol 1994; 56: 1–26
   PubMed Web of Science ®Google Scholar
• Papanicolau D A. The pathophysiological roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127–37
   PubMed Web of Science ®Google Scholar
• Wilson A G, di Giovine F S, Duff G W. Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995; 45: 1–12
   PubMedGoogle Scholar
• Takashima K, Takeda K, Matsumoto T, Iizava Y, Nakao M, Yamaguchi K. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 1997; 65: 257–60
   PubMed Web of Science ®Google Scholar
• Hack C E, Aarden L A, Thijs L G. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101–95
   PubMed Web of Science ®Google Scholar
• Eigler A, Sinha B, Hartman G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 1997; 18: 487–92
   PubMedGoogle Scholar
• Waage A, Haltensen T, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal sepsis. Lancet 1987; 1: 355–7
   PubMed Web of Science ®Google Scholar
• McDowell T J, Symons J A, Ploski R, Forre O, Duff G W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum 1995; 38: 221–8
   PubMed Web of Science ®Google Scholar
• Bailly S, di Giovine F S, Duff G W. Polymorphic tandem repeat region in interleukin-1α intron 6. Hum Genet 1993; 91: 85–6
   PubMed Web of Science ®Google Scholar
• di Giovine F S, Taksh E, Blakemore A IF, Duff G W. Single base polymorphism at -511 in the human interleukin-1β gene (IL-1β). Hum Mol Genet 1992; 1: 450
   PubMedGoogle Scholar
• Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1 β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992; 22: 396–402
   PubMed Web of Science ®Google Scholar
• Tarlow J K, Blakemore A IF, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403–4
   PubMed Web of Science ®Google Scholar
• Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998; 47: 195–8
   PubMed Web of Science ®Google Scholar
• Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 1998; 28: 2598–602
   PubMed Web of Science ®Google Scholar
• Danis V A, Millington M, Hyland V J, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303–10
   PubMed Web of Science ®Google Scholar
• Mansfield J C, Holden H, Tarlow J K, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637–42
   PubMed Web of Science ®Google Scholar
• Hacker U T, Gomolka M, Keller E, et al. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997; 40: 623–7
   PubMed Web of Science ®Google Scholar
• Tarlow J K, Clay F E, Cork M J, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994; 103: 387–90
   PubMed Web of Science ®Google Scholar
• Blakemore A IF, Tarlow J K, Cork M J, Gordon C, Emery P, Duff G W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380–5
   PubMed Web of Science ®Google Scholar
• Danis V A, Millington M, Huang Q, Hyland V, Grennan D. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. Dis Markers 1994; 12: 135–9
   Web of Science ®Google Scholar
• Clay F E, Cork M J, Tarlow J K, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994; 94: 407–10
   PubMed Web of Science ®Google Scholar
• Blakemore A IF, Watson P F, Weetman A P, Duff G W. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metah 1995; 80: 111–5
   PubMed Web of Science ®Google Scholar
• Crusius J BA, Pena A S, van Oosten B W, et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995; 346: 979–80
   PubMed Web of Science ®Google Scholar
• Huang W-X, He B, Hillert J. An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis. J Heuroimmunol 1996; 67: 143–4
   PubMed Web of Science ®Google Scholar
• Blakemore A IF, Cox A, Gonzales A M, et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369–74
   PubMed Web of Science ®Google Scholar
• Tarnow L, Pociot F, Hansen P M, et al. Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 1997; 46: 1075–6
   PubMed Web of Science ®Google Scholar
• Bioque G, Crusius J BA, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-IRa) genes in inflammatory bowel diseases. Clin Exp Immunol 1995; 102: 379–83
   PubMed Web of Science ®Google Scholar
• Heresbach D, Alizadeh M, Dabadie A, et al. Significance of interleukin-1β and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 1164–9
   PubMed Web of Science ®Google Scholar
• Kornman K S, Crane A, Wang H Y, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontal 1997; 24: 72–7
   PubMed Web of Science ®Google Scholar
• Hurme M, Helminen M. Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol, (in press)
   Web of Science ®Google Scholar
• Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120–8
   PubMed Web of Science ®Google Scholar
• Turner D M, Williams D M, Sankaran D, Lazarus M, Sinnot P J, Hutchinson I V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997; 24: 1–8
   PubMedGoogle Scholar
• Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635–9
   PubMed Web of Science ®Google Scholar
• Lazarus M, Hajeer A H, Turner D, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314–7
   PubMed Web of Science ®Google Scholar
• Hajeer A H, Lazarus M, Turner D, et al. IL-10 gene promoter polymorphism in rheumatoid arthritis. Scand J Rheumatol 1998; 27: 142–5
   PubMed Web of Science ®Google Scholar
• Westendorp R GJ, Langermans J AM, Huizinga T WJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170–3
   PubMed Web of Science ®Google Scholar